Αναζήτηση

EU support for the implementation of Slovenia's National Recovery and Resilience Plan (NRRP) amounts to €2 482.3 million, and includes €1 776.9 million in grants and €705.4 million in loans. This amount should be committed by the end of 2023, and paid out to Slovenia by the end of 2026. While the overall allocation represents only 0.3 % of the total Recovery and Resilience Facility (RRF), it stood at 5.1 % of the country's gross domestic product (GDP) in 2019 (the RRF being 5.2 % of EU-27 GDP in ...

On 6 July 2021, the Council approved Slovakia's National Recovery and Resilience Plan (NRRP, Plán obnovy) and allocated €6 328.6 million in grants for its implementation. The allocation covers almost entirely the total cost of the plan, which stands at €6 575 million. In June 2022, Slovakia's grant allocation was revised downwards to €6 007.3 million ( 5.1 %). However, thanks to the February 2023 agreement enabling Member States to add REPowerEU chapters to their plans, Slovakia's envelope will be ...

This study provides a mapping of funds contributed by different actors for the R&D and the expansion of the production capacity of COVID-19 vaccines, with a focus on those authorised in the EU. Nine vaccines are examined. It is found that governments, mainly the US (with some not-for-profit entities) decisively supported corporate investments, either for R&D, manufacturing, or both, by nearly EUR 9 billion, i.e. on average EUR one billion of grants per vaccine, with, however, vast variance across ...

These proceedings summarise the presentations and discussions during the workshop on ‘COVID-19: EU Preparedness and Response’, held on 8 March 2023. The five presentations touched, inter alia, upon the impact of COVID-19 at EU level, and how the EU has been prepared, how it responded to that crisis, and the lessons learned following the pandemic. These workshop proceedings were provided by the Policy Department for Economic, Scientific and Quality of Life Policies for the Special Committee on COVID ...

Luxembourg's National Recovery and Resilience Plan (NRRP) was initially to be financed by the Recovery and Resilience Facility (RRF) with a total of €93.4 million in grants. This allocation accounted for around 51 % of the total estimated value of the Luxembourgish NRRP (€183.1 million). Further 46 % of the costs are to be covered by the national budget, and 3 % from other EU co-financing. Under the RRF Regulation, Member States can request RRF loans until 31 August 2023; Luxembourg has not yet done ...

This study considers the consequences of measures aimed at countering the effects of COVID-19, in particular the Temporary Framework for State aid, EU Digital COVID Certificates and other measures implemented by EU Member States. The study examines the consequences of the measures on industry, small and medium-sized enterprises and focuses on the cultural and creative industries. Consequences for workers and working practices were also considered, and lessons learnt identified. This document ...

These proceedings summarise the presentations and discussions of the workshop on ‘long COVID’ organised for the European Parliament’s Special Committee on the COVID-19 pandemic on 9 March 2023. The six presentations touched, inter alia, upon the current state of knowledge on the disease’s clinical profile, potential causes and underlying mechanisms, impacts on patients and society, and lessons to be learned from post-acute infection syndromes and chronic diseases. The speakers and Members could discuss ...

This study was drawn up to support the work of the European Parliament's Special Committee on the COVID 19 pandemic. It examines the European Union's public health response to the COVID 19 pandemic across the following five pillars: (1) the EU vaccines strategy and national vaccination strategies; (2) independent scientific evidence on vaccine effectiveness; (3) the EU public health response to COVID 19, addressing the EU framework for crisis response; (4) the EU's prevention and preparedness efforts ...

On 11 November 2020, the European Commission put forward a proposal for a regulation on serious cross-border threats to health. In the light of lessons learned from the coronavirus crisis, it aimed to strengthen the EU's health security by revising Decision 1082/2013/EU (the 'Cross-Border Health Threats Decision'). The proposal was presented in a package that also included proposals to strengthen the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) ...

During the 2021-2022 epidemiological year, highly pathogenic avian influenza struck Europe, leading to the death or cull of 50 million birds across the continent, with a considerable impact on the poultry sector. While EU legislation establishes strict biosecurity measures and allows vaccine use in such cases, more research and investment is needed to reach definitive solutions.